Reader response: INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease. Ashford JW. Neurology 2020;94:593-594.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ashford JW. Reader response: INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease. Neurology 2020;94:593-594.
PMID: 32229635